Sorrento Therapeutics, Inc SRNE

Chopstick_Charlie Premium

Sorrento therapeutics is a chart that interests me. Measured move from pennant hit exactly which explains the bounce but I am anticipating a move down to horizontal support at 1.50. Will go into more detail on the daily chart. RSI flashed into oversold conditions recently however no bullish divergence. High risk high reward however any buys in this area, in the...

Susan1979 Premium

Sec.gov Contingent Consideration We have contingent consideration obligations in connection with certain acquisition and licensing transactions that are contingent upon achieving certain specified milestones or the occurrence of certain events, including those described within the accompanying notes to the consolidated financial statements in Part I, Item 1 of...

kingav69

I think this is a good place to start a position, if it breaks here next support zone is approx 3.75. High demand for tests currently a good PR from this company could send it north after a long bear trend. Good luck.

day0

SRNE possible increase around 2022-01 and 2022-02. Then a possible decrease around Spring 2022.

game_trader

Series of negative events and environment was dragging down the stock. Key resistance of 9.2 was not broken in August, taking it into downtrend. Yet, the fundamentally the company is undervalued and flies under radar. It will start grasping more attention as COVISTIX and G-MAB library products will continue progressing with approvals. In short term TA...

NRPICKS_ Premium

Sorrento Therapeutics, Inc. is a commercial and clinical-stage biopharmaceutical company developing therapies for cancer, autoimmune, inflammatory, viral and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex.

mrtnquint

Per chart analysis plotted last month, $SRNE has landed exactly at the upswing mark highlighted in the red oval. 3 point meet with resistance and support, also considering Recent PR of President Biden's demand for mandated vaccination. The Gann Square thus far has proven its success at predicting price movement. Good luck all.

mrtnquint

Following up from the prior post published, the Gann Square has continued proving its accuracy with traders. Here i highlight the plots layed out from weeks ago that has set prime levels for support and resistance. As seen, the upward trend is ready to move past resistance and into its next level as the stock tested $9.63 . A nice withdrawal from RSI will assist...

game_trader

I'm long in this stock and been studying it for quite a well. Strong pipeline and recent news on agreement with Texas A&M University System around one of it's development related to fighting Covid-19 by inhibiting MPro enzyme. The company also has several other programs to address Covid-19 as well as cancer, immunological diseases and pain. Technical set-up...

shkspr

NASDAQ:SRNE Possible Scenario: LONG Evidence: Price Action, Break-out confirmed TP1: 11.30$ Call options 17th Sep, Strike 9$ is safest bet *This is my idea and could be wrong 100%.

goodguy Pro

My last post in January was wrong. Here is how it looks to me now. Often volume drops toward the end of the triangle. Personally I will take profits at "D". Process your way. Have a good week.

mrtnquint

Looking at the 6 month trend in Sorrento after its early year uptrend, the company has released back to back catalyst. However, FDA approval has been the majority in its probability to be valued. The gann square is showing no resistance as both horizontal lines since July have not crossed 50%, they are both currently within 12%, which states full support on its...

marcavilavall Pro

I think that in final of August SRNE start a new rallie, I hope that start early than I think. On the graph you can see my prediction lines : Red -> Resistance that if overcome will become support. Orange -> Our resistance lines that we try to broke, I think that will broke the bearish trend almost late Agust, September 1th and we take over the line of 9,5$...

PennyStocks101

This could be an important area for SRNE right now. You've got Fibs and major moving averages all converging at the same point. News today: "Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain and COVID-19, announced today the availability of a...

Investor4321 Pro

$SRNE has bounced off of the .618 fib level, which could mean a break to the recent high. I am anticipating a touch to the $15 zone within the next couple of months. Good Luck!

Investor4321 Pro

Basic trend analysis says that the previous high will be broken. $SRNE could surge a lot in upcoming weeks. Good Luck!

MLinv Pro+

Sorrento is trading within the clear yellow channel. A lot is in the pipeline, but on any relevant news, according to my chart it has been perfectly trading within this pennant. Fibonacci levels will act as resistance and the price will be shorted down again when reached.

UnknownUnicorn19246015

Sorrento receives MHRA authorization to conduct Phase 2 COVI-DROPS trial Sorrento Therapeutics announced that the Medicines and Healthcare products Regulatory Agency, the United Kingdom's regulatory agency, has cleared Sorrento's COVI-DROPS product candidate for a Phase 2 efficacy trial. The application was submitted as a rolling application and the MHRA cleared...